drugset / Trial / NCT00078247

Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis

NCT00078247

RandomizedParallel-groupOpen-labelTreatment

Summary

This study is designed to determine whether 6 months of anti-HIV drugs given along with tuberculosis treatment will delay the onset of AIDS in HIV infected African patients.

Timeline

Start
2004-10
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Abacavir Other / unclassified 300 mg Oral
Subject Lamivudine Other / unclassified 300 mg Oral
Subject Zidovudine Small molecule 300 mg Oral